- Home
- FC vs ELDN Comparison
FC vs ELDN Comparison
Compare FC & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FC
- ELDN
- Stock Information
- Founded
- FC 1983
- ELDN 2004
- Country
- FC United States
- ELDN United States
- Employees
- FC N/A
- ELDN N/A
- Industry
- FC Other Consumer Services
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- FC Consumer Discretionary
- ELDN Health Care
- Exchange
- FC Nasdaq
- ELDN Nasdaq
- Market Cap
- FC 239.1M
- ELDN 202.4M
- IPO Year
- FC 1992
- ELDN N/A
- Fundamental
- Price
- FC $18.31
- ELDN $2.87
- Analyst Decision
- FC Strong Buy
- ELDN Strong Buy
- Analyst Count
- FC 2
- ELDN 2
- Target Price
- FC $27.00
- ELDN $12.50
- AVG Volume (30 Days)
- FC 112.3K
- ELDN 1.0M
- Earning Date
- FC 11-05-2025
- ELDN 11-11-2025
- Dividend Yield
- FC N/A
- ELDN N/A
- EPS Growth
- FC N/A
- ELDN N/A
- EPS
- FC 0.81
- ELDN 0.21
- Revenue
- FC $279,943,000.00
- ELDN N/A
- Revenue This Year
- FC N/A
- ELDN N/A
- Revenue Next Year
- FC $1.23
- ELDN N/A
- P/E Ratio
- FC $22.46
- ELDN $13.46
- Revenue Growth
- FC N/A
- ELDN N/A
- 52 Week Low
- FC $18.01
- ELDN $2.32
- 52 Week High
- FC $44.16
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- FC 38.39
- ELDN 55.91
- Support Level
- FC $18.06
- ELDN $2.71
- Resistance Level
- FC $19.74
- ELDN $2.71
- Average True Range (ATR)
- FC 0.77
- ELDN 0.16
- MACD
- FC -0.15
- ELDN 0.04
- Stochastic Oscillator
- FC 2.31
- ELDN 68.88
About FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.